Microsoft Threat Intelligence identified an active multi-stage intrusion campaign targeting hospitality organizations in ...

Trusted host lists can help keep PowerShell remoting working in mixed domain and workgroup environments, but only if admins avoid overwriting existing WinRM settings.

Path of Exile 2's long path to 1.0 is finally winding down. On Thursday, developer Grinding Gear Games held a digital livestream detailing the latest patch (0.5, "Return of the Ancients"), during ...

On April 23, 2026, the Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA) announced “a new pathway designed to expedite access to certain FDA-designated Class II ...

SAN FRANCISCO--(BUSINESS WIRE)--Innovaccer, a leading healthcare AI company, today announced that the Centers for Medicare & Medicaid Services (CMS) has accepted its application under Story Health ...

Threat actors are now abusing DNS queries as part of ClickFix social engineering attacks to deliver malware, making this the first known use of DNS as a channel in these campaigns. ClickFix attacks ...

New research out today from cybersecurity company watchTowr Pte. Ltd. details a new class of vulnerabilities in the .NET Framework that can allow attackers to weaponize standard SOAP client proxies ...

Pour one out for the ancient MetroCard and its equally old cousin, the PATH SmartLink card. The beginning of the end for these longtime ways to pay fares on the bi-state PATH system came Thursday when ...

The plausible mechanism pathway “could accelerate gene therapy/editing development,” analysts at William Blair said Thursday, while adding that additional clarity is needed. Individualized therapies ...

NEW YORK, Nov 12 (Reuters) - The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on data from a handful of patients, two of the ...

The Ontario government and the pan-Canadian Pharmaceutical Alliance (pCPA) announced separate initiatives in October 2025, both aimed to accelerate patient access to breakthrough cancer treatments ...